Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Immunology (2021) 12:723349. doi: 10.3389/fimmu.2021.723349
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2022
- Urheber
-
Strunz, Patrick-Pascal
Froehlich, Matthias
Gernert, Michael
Schwaneck, Eva Christina
Fleischer, Anna
Pecher, Ann-Christin
Tony, Hans-Peter
Henes, Joerg Christoph
Schmalzing, Marc
- DOI
-
10.3389/fimmu.2021.723349
- URN
-
urn:nbn:de:bvb:20-opus-245574
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Strunz, Patrick-Pascal
- Froehlich, Matthias
- Gernert, Michael
- Schwaneck, Eva Christina
- Fleischer, Anna
- Pecher, Ann-Christin
- Tony, Hans-Peter
- Henes, Joerg Christoph
- Schmalzing, Marc
- Universität Würzburg
Entstanden
- 2022
Ähnliche Objekte (12)
Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab
Gene engineering of hematopoietic stem cells for autologous transplantation in pediatrics
Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells
Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation
Autologous hematopoietic stem cell transplantation improves long-term survival - data from a national registry
Immunological consequences of cladribine treatment in multiple sclerosis : a real-world study
Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
Autologous haemotherapy
The molecular basis of differential immunological HLA-B*57:01-associated adverse drug reactions
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab
Gene engineering of hematopoietic stem cells for autologous transplantation in pediatrics
Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells
Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation
Autologous hematopoietic stem cell transplantation improves long-term survival - data from a national registry
Immunological consequences of cladribine treatment in multiple sclerosis : a real-world study
Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
Autologous haemotherapy
The molecular basis of differential immunological HLA-B*57:01-associated adverse drug reactions
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab
Gene engineering of hematopoietic stem cells for autologous transplantation in pediatrics
Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells
Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation
Autologous hematopoietic stem cell transplantation improves long-term survival - data from a national registry
Immunological consequences of cladribine treatment in multiple sclerosis : a real-world study
Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
Autologous haemotherapy
The molecular basis of differential immunological HLA-B*57:01-associated adverse drug reactions